JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition to BCR-ABL1-positive CML cells, the driver mutation JAK2-V617F-regulated lncRNA BANCR axis was further identified in BCR-ABL1-negative MPNs.